Oragenics, Inc. (OGEN)
NYSEAMERICAN: OGEN · Real-Time Price · USD
0.900
+0.011 (1.28%)
At close: Mar 6, 2026, 4:00 PM EST
0.892
-0.008 (-0.87%)
After-hours: Mar 6, 2026, 8:00 PM EST
Oragenics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | - | - | 0.04 | 0.13 | 0.09 | - | |
| Revenue Growth (YoY) | - | - | -71.37% | 51.20% | - | - | |
| Cost of Revenue | 3.39 | 4.11 | 15.49 | 10.07 | 10.59 | 22.11 | |
| Gross Profit | -3.39 | -4.11 | -15.45 | -9.94 | -10.5 | -22.11 | |
| Selling, General & Admin | 6.83 | 6.44 | 5.45 | 4.48 | 5.27 | 4.53 | |
| Other Operating Expenses | - | - | - | - | 0 | 0 | |
| Operating Expenses | 6.83 | 6.44 | 5.45 | 4.48 | 5.27 | 4.54 | |
| Operating Income | -10.22 | -10.56 | -20.9 | -14.42 | -15.77 | -26.64 | |
| Interest Expense | -0.79 | -0.03 | -0.03 | -0.02 | -0.02 | -0.01 | |
| Interest & Investment Income | 0.11 | 0.05 | 0.21 | 0.14 | 0.08 | 0.09 | |
| Currency Exchange Gain (Loss) | -0 | -0.03 | - | - | - | - | |
| Other Non Operating Income (Expenses) | - | - | 0.07 | 0.01 | 0 | 0 | |
| EBT Excluding Unusual Items | -10.9 | -10.57 | -20.66 | -14.29 | -15.71 | -26.56 | |
| Other Unusual Items | - | - | - | - | - | 0.13 | |
| Pretax Income | -10.9 | -10.57 | -20.66 | -14.29 | -15.71 | -26.43 | |
| Earnings From Continuing Operations | -10.9 | -10.57 | -20.66 | -14.29 | -15.71 | -26.43 | |
| Net Income | -10.9 | -10.57 | -20.66 | -14.29 | -15.71 | -26.43 | |
| Net Income to Common | -10.9 | -10.57 | -20.66 | -14.29 | -15.71 | -26.43 | |
| Shares Outstanding (Basic) | 1 | 0 | 0 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 1 | 0 | 0 | 0 | 0 | 0 | |
| Shares Change (YoY) | 1588.05% | 194.35% | 11.97% | 3.40% | 106.24% | 33.69% | |
| EPS (Basic) | -8.61 | -47.88 | -275.48 | -213.36 | -242.59 | -841.66 | |
| EPS (Diluted) | -8.61 | -47.88 | -275.48 | -213.36 | -242.59 | -841.66 | |
| Free Cash Flow | -8.43 | -8.6 | -7.29 | -15.36 | -13.51 | -16.95 | |
| Free Cash Flow Per Share | -6.66 | -38.95 | -97.23 | -229.30 | -208.66 | -539.85 | |
| Operating Margin | - | - | -55519.89% | -10964.61% | -18131.88% | - | |
| Profit Margin | - | - | -54858.14% | -10863.96% | -18062.03% | - | |
| Free Cash Flow Margin | - | - | -19363.34% | -11675.70% | -15535.76% | - | |
| EBITDA | - | -10.53 | -20.88 | -14.38 | -15.73 | -26.59 | |
| D&A For EBITDA | - | 0.03 | 0.03 | 0.04 | 0.04 | 0.05 | |
| EBIT | -10.22 | -10.56 | -20.9 | -14.42 | -15.77 | -26.64 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.